Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Health, Fitness, and Safety Knowledge as Determinants of Adverse Events in Recreational Divers in Poland

NCT07855861 · tracked via the Priya Life Science Poland tracker
Phase
Observational
Started
2026-10-01
Last updated
2026-10-02

Condition(s) studied

Decompression SicknessBarotraumaRecreational Diving

Investigational drug(s) / intervention(s)

Anonymous online questionnaire

Anonymous online questionnaire: Anonymous online questionnaire completed once by each participant (about 12 to 18 minutes). It captures demographic data, diving exposure and certification level, chronic health conditions, risky behaviours, estimated VO2max (University of Houston Non-Exercise Test), and a diving-safety knowledge test. No clinical procedures or biological sampling are involved; this is the observational data-collection instrument for the cohort.

Study summary

This cross-sectional online survey study assesses health status, physical fitness, and safety knowledge as potential determinants of diving-related adverse events among recreational divers in Poland. Recreational diving exposes participants to specific hazards, including decompression sickness (DCS) and barotrauma of the middle ear, sinuses, and lungs. To date, no Polish study has simultaneously evaluated health, physical fitness, theoretical safety knowledge, and the occurrence of adverse events in this population. Adult divers (18 years or older) who completed at least one dive in the past 24 months and reside in Poland complete an anonymous online questionnaire (about 12 to 18 minutes). Physical fitness is estimated as VO2max using the University of Houston Non-Exercise Test (physical activity rating, age, BMI, and sex). Knowledge of DCS, barotrauma, and safe-diving rules is tested at three difficulty levels. The questionnaire also captures diving exposure, certification level, chronic health conditions, and risky behaviours (smoking, alcohol use, and diving beyond certification). The primary endpoint is the proportion of divers reporting at least one diving-related adverse event. Associations with certification level, estimated VO2max, BMI, and other factors are analysed using multivariable logistic regression. The study is non-interventional, anonymous, and carries minimal risk; no clinical procedures or biological sampling are involved.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18 years or older * At least one dive within the past 24 months * Provision of informed consent (checkbox in the survey) * Residence in Poland (self-declared) Exclusion Criteria: * Age under 18 years * No dive within the past 24 months * No consent to participate * Incomplete completion of survey sections A-C (eligibility, demographics, diving exposure)

Primary outcome measure(s)

  • Prevalence of diving-related adverse events — At enrollment (Day 1; single cross-sectional assessment)
    Proportion of divers reporting at least one diving-related adverse event (barotrauma symptoms, decompression sickness symptoms, or other post-dive health problems) occurring at any time during the participant's diving history up to enrollment (lifetime recall). Reported as a percentage with 95% confidence interval.

Trial sites (2)

FacilityCityRegionStatus
Medical University of Bialystok, Department of Respiratory Physiopathology Bialystok Podlaskie Voivodeship
Medical University of Bialystok, II Department of Lung Diseases, Lung Cancer and Internal Medicine Bialystok Podlaskie Voivodeship
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07855861 on ClinicalTrials.gov ↗ ← All trials in Poland